IMR Press / FBL / Volume 22 / Issue 2 / DOI: 10.2741/4484

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Article

Metformin suppresses CRC growth by inducing apoptosis via ADORA1

Show Less
1 Department of Gastroenterological Surgery, The First Affiliated Hospital, Fujian Medical University, 20 Chazhong Rd, Fuzhou 350005, Fujian Province, China
2 Department of Neurology, The Affiliated Union Hospital, Fujian Medical University, 29 Xinquan Rd, Fuzhou 350001, Fujian Province, China
3 Department of Oncological Surgery, The First Hospital of Putian City, 389 Longdejing, Chengxiang District, Putian 351100, Fujian Province, China
4 Department of Gastrointestinal Medicine, The First Affiliated Hospital, Fujian Medical University, 20 Chazhong Rd, Fuzhou 350005, Fujian Province, China
5 Department of Thoracic Surgery, Shanghai, Pulmonary Hospital of Tongji University, 507 Zhengmin Rd., Shanghai 200433, China
Academic Editor:Wei Qin
Front. Biosci. (Landmark Ed) 2017, 22(2), 248–257;
Published: 1 January 2017
(This article belongs to the Special Issue Pathogenesis and diagnostic modalities in cancer)

Accumulating evidence suggests that the anti-diabetic drug, metformin, exerts anti-proliferative effects in many types of cancers. However, the function and mechanisms of metformin in human colorectal cancer (CRC) remain unknown. Here, we show that metformin induces growth inhibition and apoptosis through activating AMPK-mTOR pathway in human colorectal cancer cells. Notably, metformin treatment significantly up-regulated adenosine A1 receptor (ADORA1) expression in human colorectal cancer cells, while suppression of ADORA1 activity by its specific inhibitor rescued the growth inhibition induced by metformin. Moreover, ADORA1-mediated growth inhibition and apoptosis induced by metformin is AMPK-mTOR pathway dependent in human colorectal cancer cells. Taken together, these results indicate that metformin suppresses human colorectal cancer growth by inducing apoptosis via ADORA1, which provide evidence the anti-neoplastic effects of metformin in the treatment of human colorectal cancer.

Colorectal Cancer
Adenosine A1 Receptor
Cell Growth
Back to top